Evotec price target lowered to $8 from $11 at H.C. Wainwright

H.C. Wainwright lowered the firm’s price target on Evotec to $8 from $11 and keeps a Buy rating on the shares. The company reported another soft quarter with guidance revised down, the analyst tells investors in a research note.